Skip to content

OBGYN

Active Risk: very low General partnershipfounded 2017active for 8 yearsBeukenlaan 10, 2020 AntwerpKBO/BCE: BE 0687.833.334

Board

3 directors, last change in 2024
De Becker Ben
Director
since 20-12-2017
listed in the 2025 annual accounts, filed on 31-07-2026
Vanderheyden Tina
Director
since 20-12-2017
listed in the 2025 annual accounts, filed on 31-07-2026
Manager
since 01-10-2024 term without a fixed end
listed in the 2025 annual accounts, filed on 31-07-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each manager alone
deed of 26-11-2024

Office holders in the KBO →

Mandates through the years

3 names, the dashed line is today
De Becker Ben
Director
Vanderheyden Tina
Director
Board
Mandates as a list
  • De Becker Ben
    • Director, from 20-12-2017 to date
  • Vanderheyden Tina
    • Director, from 20-12-2017 to date
  • Nada Mourad
    • Manager, from 01-10-2024 to date

Control

Shareholders
Tina Vanderheyden, Ben De Becker, Nada Mourad
This company
OBGYN
Equity €1,848

Capital

Contribution
€2,000
Shares
3,000
Contribution per share
€0.67
Equity per share
€0.62 in 2025
Source
2025 annual accounts

Articles of association

deed of 26-11-2024 (in Dutch)
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Publiciteit van de overdracht, 1.1.6.5”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Friday of June at 18:00

Shareholders

Stated in the deed deed of 26-11-2024 ↗
  • Tina Vanderheyden 1,000 shares
  • Ben De Becker 1,000 shares
  • Nada Mourad 1,000 shares

Next steps